Evidence map›Paper›PMID 32339108›Full record

ArticleJournal of affective disorders2020

Label-free proteomics differences in the dorsolateral prefrontal cortex between bipolar disorder patients with and without psychosis.

Ada M-C Ho, Alejandra Cabello-Arreola, Matej Markota, Carrie J Heppelmann, M Cristine Charlesworth, Aysegul Ozerdem, Gouri Mahajan, Grazyna Rajkowska, Craig A Stockmeier, Mark A Frye and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of affective disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Ada M-C HoDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Alejandra Cabello-ArreolaDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Matej MarkotaDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Carrie J HeppelmannProteomics Core, Medical Genome Facility, Mayo Clinic, Rochester, MN, USA.
M Cristine CharlesworthProteomics Core, Medical Genome Facility, Mayo Clinic, Rochester, MN, USA.
Aysegul OzerdemDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Gouri MahajanPsychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, USA.
Grazyna RajkowskaPsychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, USA.
Craig A StockmeierPsychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, USA; Psychiatry, Case Western Reserve University, Cleveland, OH, USA.
Mark A FryeDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Doo-Sup ChoiDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
Marin VeldicDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. Electronic address: Veldic.Marin@mayo.edu.
Mayo Clinic · USWinnMed · USJackson Memorial Hospital · US

Funding

Role of obesity in preeclamptic pregnancy.P20GM121334 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI Babbette LaMarca, Jane F Reckelhoff · 2017 to 2026
$26.4M
Center for Psychiatric NeuroscienceP30GM103328 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI STOCKMEIER, CRAIG ALLEN · 2013 to 2017
$5.5M
Alcohol and Adenosine-Mediated Glutamate Signaling in Neuro-Glial InteractionR01AA018779 · NIAAA · MAYO CLINIC ROCHESTER · PI CHOI, DOO-SUP · 2009 to 2019
$3.8M
Postmortem Human Brain Collection (Supplement to MH67996)R01MH067996 · NIMH · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI STOCKMEIER, CRAIG ALLEN · 2004 to 2007
$1.2M
NIAAA NIH HHS R01 AA018779NIGMS NIH HHS P20 GM121334NIGMS NIH HHS P30 GM103328NIMH NIH HHS R01 MH067996
6 · The paper itself

Abstract

backgroundPsychosis is common in bipolar disorder (BD) and is related to more severe cognitive impairments. Since the molecular mechanism of BD psychosis is elusive, we conducted this study to explore the proteomic differences associated with BD psychosis in the dorsolateral prefrontal cortex (DLPFC; BA9).

methodsPostmortem DLPFC gray matter tissues from five pairs of age-matched male BD subjects with and without psychosis history were used. Tissue proteomes were identified and quantified by label-free liquid chromatography tandem mass spectrometry and then compared between groups. Statistical significance was set at q < 0.40 and Log

resultsEleven protein groups differed significantly between groups, including the reduction of tenascin C (q = 0.005, Log LIMITATIONS: Small sample size and uncertain relationships of the observed proteomic differences with illness stage and acute psychosis.

conclusionsThese results suggested BD with psychosis history may be associated with abnormalities in neurodevelopment, neuroplasticity, neurotransmission, and neuromodulation in the DLPFC.

Indexed as

Bipolar DisorderPsychotic DisordersGray MatterHumansMagnetic Resonance ImagingMalePrefrontal CortexProteomics

Identifiers

PMID32339108
PMCPMC7234814
OpenAlexW3016040469

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.